Ginkgo Bioworks Holdings Inc. (DNA)
NYSE · Healthcare
Ginkgo Bioworks Holdings Inc. Revenue 2019–2025
Ginkgo Bioworks Holdings Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Ginkgo Bioworks Holdings Inc. revenue for the quarter ending March 31, 2026 was 19.5 M, a 49.06% decrease year-over-year.
- Ginkgo Bioworks Holdings Inc. revenue for the twelve months ending March 31, 2026 was 146.1 M, a 38.76% decrease year-over-year.
- Ginkgo Bioworks Holdings Inc. annual revenue for 2025 was 170.2 M, a 25.06% decrease from 2024.
- Ginkgo Bioworks Holdings Inc. annual revenue for 2024 was 227.0 M, a 9.71% decrease from 2023.
- Ginkgo Bioworks Holdings Inc. annual revenue for 2023 was 251.5 M, a 47.36% decrease from 2022.
- Ginkgo Bioworks Holdings Inc. annual revenue for 2022 was 477.7 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ginkgo Bioworks Holdings Inc. Earnings — FAQ
Ginkgo Bioworks Holdings Inc. (DNA) earnings over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DNA's earnings history?
The chart and table above show Ginkgo Bioworks Holdings Inc.'s earnings by year and by quarter, including the growth rate.